{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:14:47Z","timestamp":1785294887908,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005936","name":"Casio Science Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JPMXS0441500024"],"award-info":[{"award-number":["JPMXS0441500024"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031308","name":"Watanabe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008883","name":"Nagoya City University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114942","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:52:47Z","timestamp":1764291167000},"page":"114942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inclusion complex of carbamazepine and hydroxypropyl-\u03b2-cyclodextrin enhances nose-to-brain delivery via improved solubility"],"prefix":"10.1016","volume":"218","author":[{"given":"Takuhiro","family":"Totoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-2127","authenticated-orcid":false,"given":"Tetsuya","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114942_b0005","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114942_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-025-00481-w","article-title":"Nose-to-brain drug delivery: from bench to bedside","volume":"14","author":"Drath","year":"2025","journal-title":"Transl. Neurodegener."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114942_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70213","article-title":"The nasal\u2013brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.ejpb.2025.114942_b0020","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","article-title":"Solubilization techniques used for poorly water-soluble drugs","volume":"14","author":"Xie","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114942_b0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","article-title":"Salt formation to improve drug solubility","volume":"59","author":"Serajuddin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ejpb.2025.114942_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081318","article-title":"Recent technologies for amorphization of poorly water-soluble drugs","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114942_b0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drudis.2010.02.009","article-title":"Nanonization strategies for poorly water-soluble drugs","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2025.114942_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2023.02.012","article-title":"Improved drug transfer into brain tissue via the \u201cnose-to-brain\u201d approach using suspension or powder formulations based on the amorphous solid dispersion technique","author":"Suwabe","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114942_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124787","article-title":"The application of cyclodextrins in drug solubilization and stabilization of nanoparticles for drug delivery and biomedical applications","volume":"666","author":"Soe","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114942_b0050","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1021\/acs.molpharmaceut.0c00672","article-title":"Preparation and biophysical characterization of quercetin inclusion complexes with \u03b2-cyclodextrin derivatives to be formulated as possible nose-to-brain quercetin delivery systems","volume":"17","author":"Manta","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114942_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124216","article-title":"Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. a stability study","volume":"659","author":"Cama","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114942_b0060","first-page":"117","article-title":"Phase solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv. Anal. Chem. Instrum.."},{"key":"10.1016\/j.ejpb.2025.114942_b0065","first-page":"113","article-title":"Formation and stability of inorganic complexes in solution","volume":"9","author":"Job","year":"1928","journal-title":"Annales De Chimie (france)."},{"key":"10.1016\/j.ejpb.2025.114942_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124632","article-title":"Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying","volume":"665","author":"Ogawa","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114942_b0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0378-5173(81)90058-2","article-title":"Absorption of drugs from the nasal mucosa of rat","volume":"7","author":"Shinichiro","year":"1981","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114942_b0080","doi-asserted-by":"crossref","unstructured":"A. Rodrigues S\u00e1 Couto, et al., Interaction of Native Cyclodextrins and Their Hydroxypropylated Derivatives with Carbamazepine in Aqueous Solution. Evaluation of Inclusion Complexes and Aggregates Formation. ACS Omega. 4. 1 (2019) 1460-1469. 10.1021\/acsomega.8b02045.","DOI":"10.1021\/acsomega.8b02045"},{"key":"10.1016\/j.ejpb.2025.114942_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.carbpol.2019.05.084","article-title":"Hydroxypropyl-\u03b2-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing","volume":"221","author":"Concei\u00e7\u00e3o","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2025.114942_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122786","article-title":"Stability of naked nucleic acids under physical treatment and powder formation: suitability for development as dry powder formulations for inhalation","volume":"15","author":"Okuda","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114942_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105514","article-title":"Patterns of drug release as a function of drug loading from amorphous solid dispersions: a comparison of five different polymers","volume":"155","author":"Saboo","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114942_b0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J. Control. Release"},{"issue":"36","key":"10.1016\/j.ejpb.2025.114942_b0105","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114942_b0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.molpharmaceut.9b01215","article-title":"Nose-to-brain delivery of cancer-targeting paclitaxel-loaded nanoparticles potentiates antitumor effects in malignant glioblastoma","volume":"17","author":"Ullah","year":"2020","journal-title":"Mol. Pharm."},{"issue":"41","key":"10.1016\/j.ejpb.2025.114942_b0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407936121","article-title":"Insulin-inspired hippocampal neuron\u2013targeting technology for protein drug delivery","volume":"121","author":"Kamei","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2025.114942_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2018.07.020","article-title":"Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain","volume":"286","author":"Ye","year":"2018","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:23:02Z","timestamp":1766139782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S0939641125003200"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114942","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion complex of carbamazepine and hydroxypropyl-\u03b2-cyclodextrin enhances nose-to-brain delivery via improved solubility","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114942"}}